Zobrazeno 1 - 10
of 177
pro vyhledávání: '"B Mark Smithers"'
Autor:
Ianthe Boden, Linda Denehy, B Mark Smithers, Natasha Reid, Claire Hackett, Peter Kruger, Nina Ripley, Rachel M Walker, Louise Hope
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Introduction Few clinical trials have investigated physiotherapy interventions to treat hypoxaemia following abdominal surgery. The objective of this study is to determine the feasibility and safety of conducting a clinical trial of physiotherapist-l
Externí odkaz:
https://doaj.org/article/d9dc50f85a234236b83959020ec17b9b
Autor:
Monika Janda, ProfPhD, Caitlin Horsham, MSc, Dimitrios Vagenas, PhD, Lois J Loescher, PhD, Nicole Gillespie, ProfPhD, Uyen Koh, PhD, Clara Curiel-Lewandrowski, MD, Rainer Hofmann-Wellenhof, ProfMD, Allan Halpern, ProfMD, David C Whiteman, ProfPhD, Jennifer A Whitty, ProfPhD, B Mark Smithers, ProfMD, H Peter Soyer, ProfFACD
Publikováno v:
The Lancet: Digital Health, Vol 2, Iss 3, Pp e129-e137 (2020)
Summary: Background: Skin self-examinations supplemented with mobile teledermoscopy might improve early detection of skin cancers compared with naked-eye skin self-examinations. We aimed to assess whether mobile teledermoscopy-enhanced skin self-exam
Externí odkaz:
https://doaj.org/article/f63bdcd6d4aa4dceb5a957dcb8dc5c0e
Autor:
Jenna E Rayner, David L Duffy, Darren J Smit, Kasturee Jagirdar, Katie J Lee, Brian De'Ambrosis, B Mark Smithers, Erin K McMeniman, Aideen M McInerney-Leo, Helmut Schaider, Mitchell S Stark, H Peter Soyer, Richard A Sturm
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0238529 (2020)
Amelanotic/hypomelanotic melanoma is a clinicopathologic subtype with absent or minimal melanin. This study assessed previously reported coding variants in albinism genes (TYR, OCA2, TYRP1, SLC45A2, SLC24A5, LRMDA) and common intronic, regulatory var
Externí odkaz:
https://doaj.org/article/62e16674d71849ccb041bfc6a1b76bc0
Autor:
Derek J Nancarrow, Andrew D Clouston, B Mark Smithers, David C Gotley, Paul A Drew, David I Watson, Sonika Tyagi, Nicholas K Hayward, David C Whiteman, Australian Cancer Study, Study of Digestive Health
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22513 (2011)
Esophageal adenocarcinoma (EAC) has become a major concern in Western countries due to rapid rises in incidence coupled with very poor survival rates. One of the key risk factors for the development of this cancer is the presence of Barrett's esophag
Externí odkaz:
https://doaj.org/article/9a2b8ba9015a43b08f811438dda18afa
Efficacy of laparoscopic fundoplication in patients with chronic cough and gastro-oesophageal reflux
Publikováno v:
Esophagus. 20:170-177
Background The outcome of anti-reflux surgery in patients with suspected gastro-oesophageal reflux-induced cough is frequently uncertain. The aims of this study were to assess the efficacy of laparoscopic fundoplication for controlling cough in patie
Autor:
Marjan M. Naeini, Felicity Newell, Lauren G. Aoude, Vanessa F. Bonazzi, Kalpana Patel, Guy Lampe, Lambros T. Koufariotis, Vanessa Lakis, Venkateswar Addala, Olga Kondrashova, Rebecca L. Johnston, Sowmya Sharma, Sandra Brosda, Oliver Holmes, Conrad Leonard, Scott Wood, Qinying Xu, Janine Thomas, Euan Walpole, G. Tao Mai, Stephen P. Ackland, Jarad Martin, Matthew Burge, Robert Finch, Christos S. Karapetis, Jenny Shannon, Louise Nott, Robert Bohmer, Kate Wilson, Elizabeth Barnes, John R. Zalcberg, B. Mark Smithers, John Simes, Timothy Price, Val Gebski, Katia Nones, David I. Watson, John V. Pearson, Andrew P. Barbour, Nicola Waddell
Publikováno v:
Nature Communications. 14
Oesophageal adenocarcinoma is a poor prognosis cancer and the molecular features underpinning response to treatment remain unclear. We investigate whole genome, transcriptomic and methylation data from 115 oesophageal adenocarcinoma patients mostly f
Autor:
B. Mark Smithers
Publikováno v:
ANZ Journal of Surgery.
Autor:
John F. Thompson, John Hyngstrom, Corrado Caracò, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Elisabetta Pennacchioli, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Alexander van Akkooi, Michael S. Sabel, Edward A. Levine, Michael Henderson, Reinhard Dummer, Carlo Riccardo Rossi, John M. Kane, Steven Trocha, Frances Wright, David R. Byrd, Maurice Matter, Alastair MacKenzie-Ross, Mark C. Kelley, Patrick Terheyden, Tara L. Huston, Jeffrey D. Wayne, Heather Neuman, B. Mark Smithers, Darius Desai, Jeffrey E. Gershenwald, Shlomo Schneebaum, Anja Gesierich, Lisa K. Jacobs, James M. Lewis, Cristina O’Donoghue, Armando Sardi, J. Greg McKinnon, Craig L. Slingluff, Jeffrey M. Farma, Erwin Schultz, Randall P. Scheri, Sergi Vidal-Sicart, Alessandro A. E. Testori, Richard A. Scolyer, David E. Elashoff, Alistair J. Cochran, Mark B. Faries
Publikováno v:
Annals of Surgical Oncology.
Autor:
Andrew P. Barbour, Kenneth Miles, Nicola Waddell, B. Mark Smithers, Samuel Yang, Gerard Bayley, Geoffrey Strutton, Phillip Law, Victoria Atkinson, Conor J. Bloxham, Julia J. Bradford, Kalpana Patel, Harald Oey, John V. Pearson, Marjan M. Naeini, Lambros T. Koufariotis, Shaun B. Walters, Sandra Brosda, Vanessa F. Bonazzi, Bernadette Z.Y. Wong, Lauren G. Aoude
Treatment for metastatic melanoma includes targeted and/or immunotherapy. Although many patients respond, only a subset has complete response. As late-stage patients often have multiple tumors in difficult access sites, non-invasive techniques are ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f97b1240044fb8b2cbde3e678fa16bff
https://doi.org/10.1158/1541-7786.c.6545076.v1
https://doi.org/10.1158/1541-7786.c.6545076.v1
Autor:
Andrew P. Barbour, Kenneth Miles, Nicola Waddell, B. Mark Smithers, Samuel Yang, Gerard Bayley, Geoffrey Strutton, Phillip Law, Victoria Atkinson, Conor J. Bloxham, Julia J. Bradford, Kalpana Patel, Harald Oey, John V. Pearson, Marjan M. Naeini, Lambros T. Koufariotis, Shaun B. Walters, Sandra Brosda, Vanessa F. Bonazzi, Bernadette Z.Y. Wong, Lauren G. Aoude
Kaplan-Meier (log-rank) analysis of MPP4 and SD3 showing the PFS and OS for stage III patients only. a. PFS for MPP4, **p=0.0017, b. OS for MPP4, *p=0.0117, c. PFS for SD3, ***p=0.0003 and d. OS for SD3, **p=0.0094.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f040cccdef8feb541b68139b6f71b5
https://doi.org/10.1158/1541-7786.22526397
https://doi.org/10.1158/1541-7786.22526397